Skip to content

Better Together Study

Better Together: A Patient-centered Approach to Improve Diabetes Among Immigrant Communities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05275231
Enrollment
108
Registered
2022-03-11
Start date
2022-04-04
Completion date
2024-01-01
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Immigrant, South Asian born Immigrant, African born Immigrant, Social Contact

Brief summary

This study (Aim 1) seeks to test that a culturally-tailored lifestyle intervention is feasible and acceptable for immigrant men from South Asia and West Africa. This will be a pre-post pilot study of a 16-week lifestyle program for South Asians and West Africans with prediabetes or diabetes in Atlanta. Patients will participate in health-professional-led group visits every other week focused on improving dietary and exercise practices to reduce weight. Groups will be followed at baseline, 4 months and 12 months. Groups will be separated by region of origin (i.e. separate groups for South Asians and West Africans). For Aim 2,the study team will assess intervention spillover effects among participant's self-identified social networks. The study team will ask participants in Aim 1 to name 5 people in their social networks to participate in a survey of health behaviors at baseline and 12-months to assess health behavior practices.

Detailed description

South Asians and Africans are growing immigrant groups at high risk for diabetes in the US. South Asian (SA) (ancestry originating from India, Pakistan, Bangladesh and other parts of South Asia) and Sub-Saharan African immigrant groups make up two of the fastest growing immigrant groups in the US. SAs have higher rates of T2D and cardiovascular disease than whites. Furthermore, SAs without diabetes have a high prevalence of T2D risk factors. Sub-Saharan African-born immigrants (the proposed study will focus on West African (WA) countries: those originating from Benin, Burkina Faso, Cape Verde, The Gambia, Ghana, Guinea, Guinea-Bissau, Ivory Coast, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, and Togo), whose population in the US has doubled every decade since 1980, are also at high risk for T2D. Dietary patterns of African immigrants are high in carbohydrates and animal protein, compared to African populations who did not immigrate. These findings in SA and African immigrant communities challenge the well-accepted healthy immigrant effect phenomenon (that immigrants are on average healthier than native-born persons), suggesting that more tailored T2D prevention and management strategies are greatly needed to narrow the disparities in outcomes between these and other US populations. Previous trials showed that intensive lifestyle interventions (ILIs), group-based programs designed to promote weight loss through a combination of diet, activity, and behavior change, decrease T2D incidence in people with prediabetes and reduced complications among people with T2D. Additional analyses have shown that the effects of lifestyle interventions are long-lasting, even when participants gain back some of the weight lost during the program. Family and social networks could be an important factor to improve patient activation, especially for South Asian and African immigrant men. Social networks, defined as someone with social or family ties to an individual, affect health through myriad mechanisms including social support, social influence, social engagement, and access to resources. This study aims to focus on SA and WA immigrant men as model populations to examine preferences, feasibility, and acceptability for a shared medical appointment (SMA) intervention based in primary care and developed with user-driven input and changes in healthy lifestyle practices among participants' social networks. This will be a pre-post pilot study of a 16-week lifestyle program for the mentioned immigrant groups with prediabetes or diabetes in Atlanta. Patients will participate in health-professional-led group visits every other week focused on improving dietary and exercise practices to reduce weight. Groups will be followed at baseline, 4 months and 12 months. For Aim 2, the study team will assess intervention spillover effects among participant's self-identified social networks. The study team will ask participants in Aim 1 to name 5 people in their social networks to participate in a survey of health behaviors at baseline and 12-months to assess health behavior practices.

Interventions

BEHAVIORALIntensive lifestyle interventions (ILIs)

Intensive lifestyle interventions (ILIs) is a group-based programs designed to promote weight loss through a combination of diet, activity, and behavior change, decrease Type 2 Diabetes (T2D) incidence in people with prediabetes and reduced complications among people with T2D.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for Aim 1: * Men \>18 years of age * Diagnosis of Type 2 Diabetes (T2D) (documented A1c of ≥ 5.7% or fasting blood glucose of \>100) or prediabetes * A family member or peer is willing to participate and attend all sessions as a social partner (if enrolling in dyad arm) * Proficiency in English(if in dyad, at least one member of each dyad) * Willingness to provide written consent Inclusion Criteria for Aim 2: * Proficient in English * Age greater than or equal to 18 years

Exclusion criteria

Aim 1 and 2: * Type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced) * Malignancy or life-threatening illness with life expectancy of \<5 years * End-stage disease or serious illness that prohibits participation (e.g. end-stage renal disease or class IV congestive heart failure) * Inability to perform unsupervised physical activity * Diagnosed with cognitive deficits or limited decision-making capacity * Alcohol or substance abuse * Homelessness or no fixed address.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Group PreferenceBaselineWhich group of the study are participants choosing between the single participant group or the dyad. Preferences will be assessed by quantifying number enrolled in each group.
Feasibility: Proportion of Subjects Who EnrollBaselineThe proportion of adults who are contacted and informed about the study and who enroll during study baseline. Feasibility will be assessed by quantifying rate of enrollment, number of sessions attended by participants (for dyad arm, will assess participant and social contact, individually and together).
Retention: Number of Sessions AttendedFrom baseline to week 16Number of sessions attended; for dyads, this would include sessions attended together and separately, over the 16-week study period. There were 5 sessions total.
Acceptability: Satisfaction QuestionnaireMonth 6Questionnaires assessed participant perceptions of ILI after the program to evaluate satisfaction with the program and suggestions for program improvement. Acceptability will be assessed by quantifying Likert-like scales of satisfaction of overall intervention. This is a 0 to 5 scale, where 0 represents the least level of satisfaction and 5 represents the highest level of satisfaction.

Other

MeasureTime frameDescription
Changes in Body WeightBaseline, month 6Participant's weight will be measured in kilograms using a calibrated, standardized scale.
Changes in Systolic Blood PressureBaseline, month 6Participant's systolic and diastolic blood pressure will be measured using standard procedures with a manual cuff. Systolic blood pressure is the amount of pressure the heart generates when pumping blood through the arteries to the body. Current guidelines identify normal systolic blood pressure as lower than 120 mmHg.
Changes in Body Mass Index (BMI)Baseline, month 6Participant's weight will be measured in kilograms using a calibrated, standardized scale, and height will be measured in meters (m), using a standardized stadiometer. BMI will be calculated using the standard formula of kg/m\^2.
Changes in DietBaseline, month 6Changes in diet will be measured using the Rapid Eating and Activity Assessment for Participants short version (REAP-S). The REAP-S consists of 13 scored questions. Responses of 'usually/often' receive 1 point, 'sometimes' receives 2 points, and 'rarely/never or does not apply to me' receives 3 points. Possible scores ranged from 13 to 39 with a higher score indicating a higher diet quality.
Change in Weight Control Strategies Scale (WCSS) Score for Social ContactsBaseline and month 6Participants' social contacts will complete the WCSS. The WCSS is a 30-item questionnaire asking about weight control practices. Responses are given on a 5-point scale when 0 = never and 4 = always. A total score is calculated by taking the average of responses and ranges from 0 to 4 where higher scores indicate greater use of strategies to lose or maintain weight.
Changes in Physical ActivityBaseline, month 6Participants will be asked to keep a daily activity log (minutes of exercise performed daily will be logged). All logged exercises will be considered physical activity. The study coordinators will measure the amount in hours of exercise performed and compare each participant's log at the different time points to asses in that subject's physical activity
Changes in Abdominal Waist CircumferenceBaseline, month 6Waist circumference will be measured in centimeters (cm) by the World Health Organization recommended method.
Changes in Diastolic Blood PressureBaseline, month 6Participant's systolic and diastolic blood pressure will be measured using standard procedures with a manual cuff. Diastolic blood pressure is the amount of pressure in the arteries when the heart is at rest between beats. Current guidelines identify normal diastolic blood pressure as lower than 80 mmHg.
Changes in Hemoglobin A1cBaseline, month 6Participant's Hemoglobin A1c (HbA1c) will be measured with a point-of-care testing (POCT) well-validated clinical instrument. Normal values for HbA1c are below 5.7% while values of 6.5% and above indicate diabetes.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from Emory Family Medicine Center. Participant enrollment began on April 4, 2022, and all follow-up assessments were completed by January 1, 2024 The study was a quasi-experimental design to understand preferences in this community. The PI offered a men-only group with very little interest in this group thus this arm was never carried forward. No subjects were enrolled in this group. Men-only group was not supposed to be a comparator arm.

Participants by arm

ArmCount
Participants
Participants who co-participated in a 5-session lifestyle intervention for diabetes management and prevention
54
Support Group
Support group comprised of participant's social partner.
54
Total108

Baseline characteristics

CharacteristicTotalParticipants
Age, Continuous52.8 years
STANDARD_DEVIATION 10.5
52.8 years
STANDARD_DEVIATION 10.5
Education
High School Graduate
5 Participants5 Participants
Education
Some College
5 Participants5 Participants
Education
Some high school
8 Participants8 Participants
Education
unknown
36 Participants36 Participants
Employment Status
Employed for wages
24 Participants24 Participants
Employment Status
Homemaker
11 Participants11 Participants
Employment Status
Retired
13 Participants13 Participants
Employment Status
Self-employed
1 Participants1 Participants
Employment Status
Student
1 Participants1 Participants
Employment Status
Unemployed
4 Participants4 Participants
English Fluency
Good
21 Participants21 Participants
English Fluency
Not good
16 Participants16 Participants
English Fluency
Not good at all
4 Participants4 Participants
English Fluency
Very good
13 Participants13 Participants
Language Spoken at Home
Mix of English/ Native
10 Participants10 Participants
Language Spoken at Home
Mostly English
0 Participants0 Participants
Language Spoken at Home
Mostly Native
43 Participants43 Participants
Language Spoken at Home
Other
1 Participants1 Participants
Marital Status
Divorced
1 Participants1 Participants
Marital Status
Married
45 Participants45 Participants
Marital Status
unknown
1 Participants1 Participants
Marital Status
Widowed
7 Participants7 Participants
Native Language
Bengali
53 Participants53 Participants
Native Language
Other
1 Participants1 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
28 Participants28 Participants
Sex: Female, Male
Male
26 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 54
other
Total, other adverse events
0 / 54
serious
Total, serious adverse events
0 / 54

Outcome results

Primary

Acceptability: Satisfaction Questionnaire

Questionnaires assessed participant perceptions of ILI after the program to evaluate satisfaction with the program and suggestions for program improvement. Acceptability will be assessed by quantifying Likert-like scales of satisfaction of overall intervention. This is a 0 to 5 scale, where 0 represents the least level of satisfaction and 5 represents the highest level of satisfaction.

Time frame: Month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureValue (MEAN)Dispersion
DyadsAcceptability: Satisfaction Questionnaire5 score on a scaleStandard Deviation 0
Primary

Feasibility: Proportion of Subjects Who Enroll

The proportion of adults who are contacted and informed about the study and who enroll during study baseline. Feasibility will be assessed by quantifying rate of enrollment, number of sessions attended by participants (for dyad arm, will assess participant and social contact, individually and together).

Time frame: Baseline

Population: No data was collected on the support group for this outcome measure. 122 is the number of people who were approached for the study.

ArmMeasureValue (NUMBER)
DyadsFeasibility: Proportion of Subjects Who Enroll54 participants enrolled
Primary

Recruitment Group Preference

Which group of the study are participants choosing between the single participant group or the dyad. Preferences will be assessed by quantifying number enrolled in each group.

Time frame: Baseline

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureValue (NUMBER)
DyadsRecruitment Group Preference54 participants
Primary

Retention: Number of Sessions Attended

Number of sessions attended; for dyads, this would include sessions attended together and separately, over the 16-week study period. There were 5 sessions total.

Time frame: From baseline to week 16

Population: The data collected for this outcome is only for the sessions attended together.

ArmMeasureValue (MEAN)Dispersion
DyadsRetention: Number of Sessions Attended4.7 sessionsStandard Deviation 0.53
Other Pre-specified

Change in Weight Control Strategies Scale (WCSS) Score for Social Contacts

Participants' social contacts will complete the WCSS. The WCSS is a 30-item questionnaire asking about weight control practices. Responses are given on a 5-point scale when 0 = never and 4 = always. A total score is calculated by taking the average of responses and ranges from 0 to 4 where higher scores indicate greater use of strategies to lose or maintain weight.

Time frame: Baseline and month 6

Other Pre-specified

Changes in Abdominal Waist Circumference

Waist circumference will be measured in centimeters (cm) by the World Health Organization recommended method.

Time frame: Baseline, month 6

Other Pre-specified

Changes in Body Mass Index (BMI)

Participant's weight will be measured in kilograms using a calibrated, standardized scale, and height will be measured in meters (m), using a standardized stadiometer. BMI will be calculated using the standard formula of kg/m\^2.

Time frame: Baseline, month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in Body Mass Index (BMI)Baseline26.56 kg/m2Standard Deviation 3.71
DyadsChanges in Body Mass Index (BMI)Month 625.92 kg/m2Standard Deviation 4.94
Other Pre-specified

Changes in Body Weight

Participant's weight will be measured in kilograms using a calibrated, standardized scale.

Time frame: Baseline, month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in Body WeightBaseline155.4 poundsStandard Deviation 25.96
DyadsChanges in Body WeightMonth 6152.8 poundsStandard Deviation 25.6
Other Pre-specified

Changes in Diastolic Blood Pressure

Participant's systolic and diastolic blood pressure will be measured using standard procedures with a manual cuff. Diastolic blood pressure is the amount of pressure in the arteries when the heart is at rest between beats. Current guidelines identify normal diastolic blood pressure as lower than 80 mmHg.

Time frame: Baseline, month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in Diastolic Blood PressureBaseline76.32 mm of HGStandard Deviation 7.65
DyadsChanges in Diastolic Blood PressureMonth 676.0 mm of HGStandard Deviation 7.5
Other Pre-specified

Changes in Diet

Changes in diet will be measured using the Rapid Eating and Activity Assessment for Participants short version (REAP-S). The REAP-S consists of 13 scored questions. Responses of 'usually/often' receive 1 point, 'sometimes' receives 2 points, and 'rarely/never or does not apply to me' receives 3 points. Possible scores ranged from 13 to 39 with a higher score indicating a higher diet quality.

Time frame: Baseline, month 6

Population: The average was collected by analyzing the points scored on each item (points rated 1-3).~No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in DietBaseline2.140 score on a scaleStandard Deviation 1.3
DyadsChanges in DietMonth 62.05 score on a scaleStandard Deviation 1.31
Other Pre-specified

Changes in Hemoglobin A1c

Participant's Hemoglobin A1c (HbA1c) will be measured with a point-of-care testing (POCT) well-validated clinical instrument. Normal values for HbA1c are below 5.7% while values of 6.5% and above indicate diabetes.

Time frame: Baseline, month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in Hemoglobin A1cBaseline7.57 percentage of HbA1CStandard Deviation 1.49
DyadsChanges in Hemoglobin A1cMonth 66.72 percentage of HbA1CStandard Deviation 0.81
Other Pre-specified

Changes in Physical Activity

Participants will be asked to keep a daily activity log (minutes of exercise performed daily will be logged). All logged exercises will be considered physical activity. The study coordinators will measure the amount in hours of exercise performed and compare each participant's log at the different time points to asses in that subject's physical activity

Time frame: Baseline, month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in Physical ActivityBaseline130.7 minutes/ weekStandard Deviation 187.8
DyadsChanges in Physical ActivityMonth 6245.5 minutes/ weekStandard Deviation 154.9
Other Pre-specified

Changes in Systolic Blood Pressure

Participant's systolic and diastolic blood pressure will be measured using standard procedures with a manual cuff. Systolic blood pressure is the amount of pressure the heart generates when pumping blood through the arteries to the body. Current guidelines identify normal systolic blood pressure as lower than 120 mmHg.

Time frame: Baseline, month 6

Population: No data was collected from the support group for this Outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
DyadsChanges in Systolic Blood PressureBaseline129.7 mm of HgStandard Deviation 19.4
DyadsChanges in Systolic Blood PressureMonth 6123.9 mm of HgStandard Deviation 13.95

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026